Efficacy and safety of edoxaban versus enoxaparin for the prevention of venous thromboembolism following total hip arthroplasty: STARS J-V.

Fuji, Takeshi; Fujita, Satoru; Kawai, Yohko; Nakamura, Mashio; Kimura, Tetsuya; Fukuzawa, Masayuki; Abe, Kenji; Tachibana, Shintaro.

Afiliação

Fuji T; Department of Orthopaedic Surgery, Japan Community Healthcare Organization Osaka Hospital, 4-2-78, Fukushima, Fukushima-ku, Osaka 553-0003 Japan.
Fujita S; Department of Orthopaedic Surgery, Takarazuka Daiichi Hospital, 19-5 Kogetsu-cho, Takarazuka, 665-0832 Japan.
Kawai Y; International University of Health and Welfare, 8-10-16 Akasaka Minato-ku, Tokyo, 107-0002 Japan.
Nakamura M; Department of Clinical Cardiovascular Research, Mie University Graduate School of Medicine, 2-174 Edobashi, Tsu, 514-8507 Japan.
Kimura T; Clinical Planning Department, Daiichi Sankyo Co. Ltd, 1-2-58, Hiromachi, Shinagawa-ku, Tokyo, 140-8710 Japan.
Fukuzawa M; Clinical Execution Department, Daiichi Sankyo Co. Ltd, 1-2-58, Hiromachi, Shinagawa-ku, Tokyo, 140-8710 Japan.
Abe K; Clinical Data & Biostatistics Department, Daiichi Sankyo Co. Ltd, 1-2-58, Hiromachi, Shinagawa-ku, Tokyo, 140-8710 Japan.
Tachibana S; Department of Orthopaedic Surgery, Mishuku Hospital, 5-33-12 Shimomeguro, Meguro-ku, Tokyo, 153-0051 Japan.

Thromb J ; 13: 27, 2015.

Article em En | MEDLINE | ID: mdl-26269694